Total Payments
$14,984
2024 Payments
$3,479
Companies
51
Transactions
844
Medicare Patients
3,685
Medicare Billing
$306,927
Payment Breakdown by Category
Food & Beverage$14,984 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,984 | 844 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,402 | 143 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,742 | 72 | $0 (2024) |
| Novo Nordisk Inc | $1,516 | 90 | $0 (2024) |
| Lilly USA, LLC | $893.52 | 63 | $0 (2024) |
| PFIZER INC. | $774.18 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $702.19 | 39 | $0 (2024) |
| Amgen Inc. | $667.74 | 33 | $0 (2024) |
| Abbott Laboratories | $629.94 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $597.35 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $523.81 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,479 | 195 | ABBVIE INC. ($589.34) |
| 2023 | $3,080 | 175 | AstraZeneca Pharmaceuticals LP ($391.38) |
| 2022 | $3,036 | 163 | ABBVIE INC. ($495.78) |
| 2021 | $3,476 | 200 | AbbVie Inc. ($831.99) |
| 2020 | $1,285 | 81 | Allergan, Inc. ($241.41) |
| 2019 | $522.19 | 29 | Amgen Inc. ($187.62) |
| 2017 | $105.36 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($105.36) |
All Payment Transactions
844 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Neurology | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Diabetes Care | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: GI | ||||||
| 10/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,209 | 1,632 | $222,499 | $99,576 |
| 2022 | 11 | 984 | 1,326 | $194,841 | $89,447 |
| 2021 | 15 | 853 | 1,114 | $162,497 | $76,893 |
| 2020 | 11 | 639 | 854 | $97,024 | $41,011 |
Total Patients
3,685
Total Services
4,926
Medicare Billing
$306,927
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 360 | 602 | $110,346 | $45,789 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 229 | 229 | $51,537 | $27,764 | 53.9% |
| 99493 | Follow-up psychiatric collaborative care management, subsequent calendar month, first 60 minutes | Office | 2023 | 11 | 49 | $14,259 | $5,190 | 36.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $9,639 | $4,785 | 49.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 342 | 422 | $6,330 | $3,529 | 55.8% |
| 99494 | Psychiatric collaborative care management per calendar month, each additional 30 minutes | Office | 2023 | 12 | 49 | $7,252 | $2,110 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 31 | $4,004 | $1,984 | 49.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,504 | $1,873 | 53.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $2,121 | $1,511 | 71.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,866 | $1,401 | 36.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $1,512 | $1,022 | 67.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,194 | $815.85 | 37.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $714.00 | $482.46 | 67.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 26 | 28 | $1,680 | $407.25 | 24.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 36 | $1,591 | $344.85 | 21.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 29 | $1,102 | $269.00 | 24.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 12 | 12 | $576.00 | $262.80 | 45.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 17 | $272.00 | $37.40 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 323 | 578 | $102,884 | $43,129 | 41.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 218 | 218 | $47,742 | $26,853 | 56.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 33 | 37 | $19,758 | $7,703 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 68 | $8,228 | $3,818 | 46.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 44 | 44 | $3,871 | $3,012 | 77.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 13 | 13 | $3,835 | $2,055 | 53.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 61 | 61 | $2,562 | $1,625 | 63.4% |
About Dr. Luke Wicke, DO
Dr. Luke Wicke, DO is a Family Medicine healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2012. The National Provider Identifier (NPI) number assigned to this provider is 1588926620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luke Wicke, DO has received a total of $14,984 in payments from pharmaceutical and medical device companies, with $3,479 received in 2024. These payments were reported across 844 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($14,984).
As a Medicare-enrolled provider, Wicke has provided services to 3,685 Medicare beneficiaries, totaling 4,926 services with total Medicare billing of $306,927. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties General Practice
- Location Joplin, MO
- Active Since 06/14/2012
- Last Updated 07/19/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1588926620
Products in Payments
- VRAYLAR (Drug) $1,301
- BREZTRI (Drug) $829.22
- NURTEC ODT (Drug) $761.99
- UBRELVY (Drug) $725.95
- FARXIGA (Drug) $681.20
- Ozempic (Drug) $547.31
- FREESTYLE LIBRE (Device) $426.83
- JARDIANCE (Drug) $398.97
- Aimovig (Biological) $375.63
- SPRAVATO (Drug) $303.95
- SHINGRIX (Biological) $300.24
- QULIPTA (Drug) $298.84
- BELSOMRA (Drug) $291.00
- Auvelity (Drug) $289.38
- TRULICITY (Drug) $282.86
- Wegovy (Drug) $278.69
- REXULTI (Drug) $278.27
- Rybelsus (Drug) $253.64
- EMGALITY (Drug) $235.06
- ZENPEP (Drug) $229.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Joplin
Dr. Maria Fe Bruce, Md, MD
Family Medicine — Payments: $12,947
Family Medicine $12,947
Troy D'amour, Do, DO
Family Medicine — Payments: $11,869
Family Medicine $11,869
James Dailey, D.o, D.O
Family Medicine — Payments: $9,990
Family Medicine $9,990
Sean Pfeffer, Md, MD
Family Medicine — Payments: $9,746
Family Medicine $9,746
William Hughes, Do, DO
Family Medicine — Payments: $7,047
Family Medicine $7,047
Amanda Andrade, Do, DO
Family Medicine — Payments: $6,472
Family Medicine $6,472